tetano
Editor, Senior Moderator
Vaccine. 2012 Oct 5. pii: S0264-410X(12)01415-6. doi: 10.1016/j.vaccine.2012.09.071. [Epub ahead of print]
Development of new generation influenza vaccines: Recipes for success?
Pronker ES, Claassen E, Osterhaus AD.
Source
Vacceleron, Jenalaan 18c, 3584 CK Utrecht, The Netherlands. Electronic address: e.s.pronker@gmail.com.
Abstract
As infectious diseases cause approximately 25% of the annual global mortality, vaccines are found to be a time proven and promising response to infectious disease need. However, like for pharmaceutical small molecules, vaccine development is lengthy, risky and resource demanding. Faced with an attrition rate estimated around 80%, key opinion leaders were interviewed with the question: is there a recipe for success?
Copyright ? 2012 Elsevier Ltd. All rights reserved.
PMID:
23044407
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23044407
Development of new generation influenza vaccines: Recipes for success?
Pronker ES, Claassen E, Osterhaus AD.
Source
Vacceleron, Jenalaan 18c, 3584 CK Utrecht, The Netherlands. Electronic address: e.s.pronker@gmail.com.
Abstract
As infectious diseases cause approximately 25% of the annual global mortality, vaccines are found to be a time proven and promising response to infectious disease need. However, like for pharmaceutical small molecules, vaccine development is lengthy, risky and resource demanding. Faced with an attrition rate estimated around 80%, key opinion leaders were interviewed with the question: is there a recipe for success?
Copyright ? 2012 Elsevier Ltd. All rights reserved.
PMID:
23044407
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23044407